Greenshoe

SelectQuote Announces Proposed Secondary Public Offering of Common Stock by Selling Stockholders

Retrieved on: 
Monday, March 1, 2021

All of the shares that would be sold in the offering would be sold by the Selling Stockholders.

Key Points: 
  • All of the shares that would be sold in the offering would be sold by the Selling Stockholders.
  • The underwriters will have a 30-day option to purchase up to an additional 1,590,000 shares of common stock from Selling Stockholders.
  • SelectQuote is not selling any shares of common stock and will not receive any proceeds from the proposed offering.
  • The proposed offering will not change the number of shares of common stock that are currently outstanding.

First Republic Bank Announces Common Stock Offering

Retrieved on: 
Monday, March 1, 2021

First Republic Bank (First Republic) (NYSE: FRC), a leading private bank and wealth management company, today announced that it has agreed to sell 1,500,000 shares of its common stock in an underwritten public offering.

Key Points: 
  • First Republic Bank (First Republic) (NYSE: FRC), a leading private bank and wealth management company, today announced that it has agreed to sell 1,500,000 shares of its common stock in an underwritten public offering.
  • First Republic has also granted the underwriters a 30-day option to purchase up to an additional 225,000 shares from First Republic.
  • First Republic intends to use the net proceeds from the offering for general corporate purposes, which may include, among other things, funding loans or purchasing investment securities for its portfolio.
  • Closing of the offering is expected to occur on or about March 4, 2021, subject to customary closing conditions.

Medigus Closes $8.5 Million Underwritten Public Offering of American Depositary Shares

Retrieved on: 
Monday, March 1, 2021

OMER, Israel, March 01, 2021 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions and innovative internet technologies, today announced the closing of an underwritten public offering of 3,258,438 American Depositary Shares (the ADSs).

Key Points: 
  • OMER, Israel, March 01, 2021 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions and innovative internet technologies, today announced the closing of an underwritten public offering of 3,258,438 American Depositary Shares (the ADSs).
  • The gross proceeds to the Company from this offering are expected to be approximately $8.5 million before deducting underwriting discounts and commissions and other estimated offering expenses payable by the Company.
  • The Company intends to use the net proceeds from this offering for working capital and general corporate purposes.
  • If the over-allotment option is exercised in full it would increase the total gross proceeds of the offering to approximately $9.7 million.

Flame Acquisition Corp. Announces Closing of $287.5 Million Initial Public Offering

Retrieved on: 
Monday, March 1, 2021

Flame Acquisition Corp. (the Company) announced today the closing of its initial public offering of 28,750,000 units, which included the full exercise of the underwriters over-allotment option, at a price of $10.00 per unit, resulting in gross proceeds of $287,500,000.

Key Points: 
  • Flame Acquisition Corp. (the Company) announced today the closing of its initial public offering of 28,750,000 units, which included the full exercise of the underwriters over-allotment option, at a price of $10.00 per unit, resulting in gross proceeds of $287,500,000.
  • The units began trading on The New York Stock Exchange (NYSE) under the ticker symbol FLME.U on February 25, 2021.
  • No fractional warrants will be issued upon separation of the units and only whole warrants will trade.
  • Cowen and Intrepid Partners served as joint book-running managers for the offering.

Cartesian Growth Corporation Announces Closing of $345 Million Initial Public Offering

Retrieved on: 
Friday, February 26, 2021

New York, NY, Feb. 26, 2021 (GLOBE NEWSWIRE) -- Cartesian Growth Corporation (the Company) announced today the closing of its initial public offering of 34,500,000 units, including 4,500,000 units pursuant to the exercise of the underwriters over-allotment option.

Key Points: 
  • New York, NY, Feb. 26, 2021 (GLOBE NEWSWIRE) -- Cartesian Growth Corporation (the Company) announced today the closing of its initial public offering of 34,500,000 units, including 4,500,000 units pursuant to the exercise of the underwriters over-allotment option.
  • The Companys sponsor is an affiliate of Cartesian Capital Group, LLC, a global private equity firm specializing in providing growth capital to transnational businesses.
  • For more information about Cartesian Growth Corporation, please visit www.cartesiangrowth.com.
  • This press release contains statements that constitute forward-looking statements, including with respect to the proposed initial public offering and the anticipated use of the net proceeds thereof.

Colicity Inc. Announces Closing of $345 Million Initial Public Offering

Retrieved on: 
Friday, February 26, 2021

Colicity Inc. (the Company) announced the closing today of its initial public offering of 34,500,000 units, including the underwriters exercise of their full over-allotment option for 4,500,000 units, at a price of $10.00 per unit.

Key Points: 
  • Colicity Inc. (the Company) announced the closing today of its initial public offering of 34,500,000 units, including the underwriters exercise of their full over-allotment option for 4,500,000 units, at a price of $10.00 per unit.
  • Goldman Sachs & Co. LLC and PJT Partners LP were the joint book-running managers of the offering.
  • The Company has granted the underwriters a 45-day option to purchase up to an additional 4,500,000 units at the initial public offering price to cover over-allotments if any.
  • Cautionary Note Concerning Forward-Looking Statements This press release contains statements that constitute forward-looking statements, including with respect to the initial public offering and search for an initial business combination.

BriaCell Announces Closing of US$25 Million Public Offering

Retrieved on: 
Friday, February 26, 2021

The aggregate gross proceeds to the Company from the offering were approximately US$25 million, before deducting underwriting discounts, commissions and other offering expenses.

Key Points: 
  • The aggregate gross proceeds to the Company from the offering were approximately US$25 million, before deducting underwriting discounts, commissions and other offering expenses.
  • In connection with the closing of this offering, the underwriter has exercised its over-allotment option to purchase an additional 882,352 warrants.
  • ThinkEquity, a division of Fordham Financial Management, Inc., acted as sole book-running manager for the offering.
  • BriaCell is an immuno-oncology focused biotechnology company developing targeted and effective approaches for the management of cancer.

Field Trip Health Announces Upsize to Previously Announced Bought Deal Public Offering

Retrieved on: 
Friday, February 26, 2021

Pursuant to the upsized deal terms, the Underwriters have agreed to purchase, on a bought deal basis, 12,750,000 common shares of Field Trip (Common Shares), at a price of C$6.50 per Common Share (the Issue Price), for aggregate gross proceeds of $82,875,000 (the Offering).

Key Points: 
  • Pursuant to the upsized deal terms, the Underwriters have agreed to purchase, on a bought deal basis, 12,750,000 common shares of Field Trip (Common Shares), at a price of C$6.50 per Common Share (the Issue Price), for aggregate gross proceeds of $82,875,000 (the Offering).
  • Field Trip intends to use the net proceeds from the Offering for the ongoing development of the FT-104 novel psychedelic development program, the opening of new Field Trip Health centers, and for working capital and general corporate purposes.
  • In the event that the Over-Allotment Option is exercised in its entirety, the aggregate gross proceeds of the Offering will be $95,306,250.
  • About Field Trip Health Ltd.
    Field Trip is the global leader in the development and delivery of psychedelic therapies.

Streamline Health Announces Pricing of Upsized $14 Million Public Offering of Common Stock

Retrieved on: 
Friday, February 26, 2021

Additionally, in connection with the offering, Streamline Health granted the underwriter a 30-day option to purchase up to an additional 1,312,500 shares of its common stock on the same terms and conditions.

Key Points: 
  • Additionally, in connection with the offering, Streamline Health granted the underwriter a 30-day option to purchase up to an additional 1,312,500 shares of its common stock on the same terms and conditions.
  • All of the securities in the offering are being sold by Streamline Health.
  • The gross proceeds from the offering to Streamline Health are expected to be $14.0million, before deducting underwriting discounts and commissions and estimated offering expenses payable by Streamline Health, but excluding any exercise of the underwriters option to purchase additional shares of common stock.
  • Streamline Health intends to use the net proceeds from the offering for working capital and general corporate purposes.

Bite Acquisition Corp. Announces Exercise of Underwriters’ Over-allotment Option in Connection With Its Initial Public Offering

Retrieved on: 
Thursday, February 25, 2021

Bite Acquisition Corp. (the Company) announced today that the underwriters of its previously announced initial public offering of units have partially exercised their over-allotment option, resulting in the issuance of an additional 2,500,000 units at a public offering price of $10.00 per unit.

Key Points: 
  • Bite Acquisition Corp. (the Company) announced today that the underwriters of its previously announced initial public offering of units have partially exercised their over-allotment option, resulting in the issuance of an additional 2,500,000 units at a public offering price of $10.00 per unit.
  • After giving effect to the exercise of the option, an aggregate of 20,000,000 units have been issued in the initial public offering at an aggregate offering price of $200,000,000.
  • The units are listed on the New York Stock Exchange and trade under the ticker symbol BITE.U.
  • Registration statements relating to these securities were declared effective by the Securities and Exchange Commission (SEC) on February 11, 2021.